Retraction: SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling (Oncology Reports (2012) 28 (311-318) DOI: 10.3892/or.2012.1788);SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 311-318

  Wang, Hanning ^a   Liu, Hao ^b   Chen, Kaiyun ^a   Xiao, Jinfeng ^a   He, Ke ^a   Zhang, Jinqian ^c   Xiang, Guoan ^a  

^a GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; PI3K PTEN AKT; SIRT1; Tumorigenesis

Indexed keywords

CASPASE 3; CASPASE 7; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SIRTUIN 1;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84861563201     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2023.8547     Document Type: Erratum

References (36)

1. Imai S, Armstrong CM, Kaeberlein M and Guarente L: Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403: 795-800, 2000. (Pubitemid 30111843)
2. Guarente L: Sir2 links chromatin silencing, metabolism, and aging. Genes Dev 14: 1021-1026, 2000.
3. Smith JS, Brachmann CB, Celic I, et al: A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc Natl Acad Sci USA 97: 6658-6663, 2000. (Pubitemid 30412770)
4. Ford J, Jiang M and Milner J: Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res 65: 10457-10463, 2005. (Pubitemid 41743740)
5. Kennedy BK, Gotta M, Sinclair DA, et al: Redistribution of silencing proteins from telomeres to the nucleolus is associated with extension of life span in S. cerevisiae. Cell 89: 381-391, 1997. (Pubitemid 27220883)
6. Sinclair DA and Guarente L: Extrachromosomal rDNA circles - a cause of aging in yeast. Cell 91: 1033-1042, 1997. (Pubitemid 28027835)
7. Lin SJ, Defossez PA and Guarente L: Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289: 2126-2128, 2000.
8. Luo J, Nikolaev AY, Imai S, et al: Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148, 2001. (Pubitemid 33035941)
9. Vaziri H, Dessain SK, Ng Eaton E, et al: hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159, 2001. (Pubitemid 33035942)
10. Baylin SB and Ohm JE: Epigenetic gene silencing in cancer, a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6: 107-116, 2006. (Pubitemid 43361543)
11. Chen WY, Wang DH, Yen RC, et al: Tumor suppressor HIC1 directly regulates to modulate p53-dependent DNA-damage responses. Cell 123: 437-448, 2005. (Pubitemid 41546674)
12. Lim CS: Human SIRT1: a potential biomarker for tumorigenesis? Cell Biol Int 31: 636-637, 2007.
13. Saunders LR and Verdin E: Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 26: 5489-5504, 2007. (Pubitemid 47255930)
14. Choi HN, Bae JS, Jamiyandorj U, et al: Expression and role of SIRT1 in hepatocellular carcinoma. Oncol Rep 26: 503-510, 2011.
15. Hida Y, Kubo Y, Murao K and Arase S: Strong expression of a longevity-related protein, SIRT1, in Bowen's disease. Arch Dermatol Res 299: 103-106, 2007. (Pubitemid 46669407)
16. Kuzmichev A, Margueron R, Vaquero A, et al: Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci USA 102: 1859-1864, 2005. (Pubitemid 40261977)
17. Huffman DM, Grizzle WE, Bamman MM, et al: is significantly elevated in mouse and human prostate cancer. Cancer Res 67: 6612-6618, 2007. (Pubitemid 47105506)
18. Jang KY, Kim KS, Hwang SH, et al: Expression and prognostic significance of SIRT1 in ovarian epithelial tumours. Pathology 41: 366-371, 2009.
19. Jang KY, Hwang SH, Kwon KS, et al: SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma. Am J Surg Pathol 32: 1523-1531, 2008.
20. Blander G and Guarente L: The Sir2 family of protein deacetylases. Annu Rev Biochem 73: 417-435, 2004. (Pubitemid 39050375)
21. Jiang M and Milner J: Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Genes Dev 17: 832-827, 2003.
22. Jiang M, Rubbi CP and Milner J: Gel-based application of siRNA to human epithelial cancer cells induces RNAi-dependent apoptosis. Oligonucleotides 14: 239-248, 2004. (Pubitemid 40144362)
23. Kim DH, Longo M, Han Y, et al: Interferon induction by siRNAs and ssRNAs synthesised by phage polymerase. Nat Biotechnol 22: 321-325, 2004. (Pubitemid 38295765)
24. Hamamoto R, Furukawa Y, Morita M, et al: SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 6: 731-740, 2004. (Pubitemid 39144478)
25. Li H, Bergeron L, Cryns V, et al: Activation of caspase-2 in apoptosis. J Biol Chem 272: 21010-21017, 1997. (Pubitemid 27373957)
26. Lavu S, Boss O, Elliott PJ, et al: Sirtuins - novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov 7: 841-853, 2008.
27. Haigis MC and Guarente LP: Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction. Genes Dev 20: 2913-2921, 2006. (Pubitemid 44771725)
28. Deng CX: SIRT1, is it a tumor promoter or tumor suppressor?Int J Biol Sci 5: 147-152, 2009.
29. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
30. Befeler AS and Di Bisceglie AM: Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122: 1609-1619, 2002. (Pubitemid 34533556)
31. Haigis MC and Sinclair DA: Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5: 253-295, 2010.
32. Brooks CL and Gu W: How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 9: 123-128, 2009.
33. Ikenoue T, Inoki K, Zhao B and Guan KL: PTEN acetylation modulates its interaction with PDZ domain. Cancer Res 68: 6908-6912, 2008.
34. Datta SR, Brunet A and Greenberg ME: Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927, 1999.
35. Okumura K, Mendoza M, Bachoo RM, et al: PCAF modulates PTEN activity. J Biol Chem 281: 26562-26568, 2006. (Pubitemid 44401865)
36. Ming M, Shea CR, Guo X, et al: Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C. Proc Natl Acad Sci USA 107: 22623-22628, 2010.